This grant opportunity, administered by NIH with funds from FDA-CTP, seeks R21 applications for exploratory research utilizing existing biospecimen collections in the United States. Emphasizing collections like PATH Study, NHANES, BioLINCC, and PLCO Trial, the grant aims to enhance the scientific value of stored samples and facilitate preliminary data generation for future research proposals. Prioritizing nationally representative analyses, applicants must justify the unique aspects of their chosen dataset. The outcomes are expected to contribute directly to FDA’s tobacco product regulation to safeguard public health. Projects must align with FDA-CTP research priorities. Closing Date: Mar 08, 2021
Opportunity ID: 318128
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-OD-19-021 |
| Funding Opportunity Title: | Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 7 |
| Assistance Listings: | 93.077 — Family Smoking Prevention and Tobacco Control Act Regulatory Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 08, 2019 |
| Last Updated Date: | Jul 08, 2019 |
| Original Closing Date for Applications: | Mar 08, 2021 |
| Current Closing Date for Applications: | Mar 08, 2021 |
| Archive Date: | Apr 13, 2021 |
| Estimated Total Program Funding: | $1,500,000 |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public housing authorities/Indian housing authorities State governments Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Special district governments For profit organizations other than small businesses Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Private institutions of higher education County governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to invite R21 applications to stimulate exploratory research relevant to the mission of the Food and Drug Administration (FDA) – Center for Tobacco Products (CTP) using existing (publicly available) biospecimen currently stored in repositories in the United States. Including, but not limited to, collections associated with the Population Assessment of Tobacco and Health (PATH) Study, the National Health and Nutrition Examination Survey (NHANES), the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC), and the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Aiming to maximize the scientific value of these stored collections and to provide researchers with an opportunity to generate preliminary data for subsequent research proposals. Other publicly available datasets would be considered, depending on analyses to be conducted, but nationally representative analyses will receive priority. These applications need to provide justification why the data set is unique and the research questions cannot be answered from a publicly available, national representative, data set. The awards under this FOA will be administered by NIH using funds that have been made available through FDA-CTP and the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31). Research results from this FOA are expected to generate findings and data that are directly relevant in informing the FDA’s regulation of the manufacture, distribution, and marketing of tobacco products to protect public health. Research Projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) – Center for Tobacco Products (CTP). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-021.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00252710 | Sep 09, 2019 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259773 | Sep 09, 2019 | Mar 08, 2021 | View |
Package 1
Mandatory forms
318128 RR_SF424_2_0-2.0.pdf
318128 PHS398_CoverPageSupplement_4_0-4.0.pdf
318128 RR_OtherProjectInfo_1_4-1.4.pdf
318128 PerformanceSite_2_0-2.0.pdf
318128 RR_KeyPersonExpanded_2_0-2.0.pdf
318128 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
318128 RR_Budget_1_4-1.4.pdf
318128 RR_SubawardBudget30_1_4-1.4.pdf
318128 PHS398_ModularBudget_1_2-1.2.pdf
318128 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
318128 RR_SF424_2_0-2.0.pdf
318128 PHS398_CoverPageSupplement_5_0-5.0.pdf
318128 RR_OtherProjectInfo_1_4-1.4.pdf
318128 PerformanceSite_2_0-2.0.pdf
318128 RR_KeyPersonExpanded_2_0-2.0.pdf
318128 PHS398_ResearchPlan_4_0-4.0.pdf
318128 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
318128 RR_Budget_1_4-1.4.pdf
318128 RR_SubawardBudget30_1_4-1.4.pdf
318128 PHS398_ModularBudget_1_2-1.2.pdf
318128 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
